These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6162434)

  • 1. Toxicokinetic and toxicodynamic studies of beryllium.
    Stiefel T; Schulze K; Zorn H; Tölg G
    Arch Toxicol; 1980 Jul; 45(2):81-92. PubMed ID: 6162434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
    Amicosante M; Deubner D; Saltini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):175-9. PubMed ID: 16315779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
    Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C
    Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomonitoring of 20 trace elements in blood and urine of occupationally exposed workers by sector field inductively coupled plasma mass spectrometry.
    Ivanenko NB; Ivanenko AA; Solovyev ND; Zeimal' AE; Navolotskii DV; Drobyshev EJ
    Talanta; 2013 Nov; 116():764-9. PubMed ID: 24148471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mechanisms in beryllium lung disease.
    Deodhar SD; Barna BP
    Cleve Clin J Med; 1991; 58(2):157-60. PubMed ID: 2025920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
    Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
    J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EVIDENCE FOR SPECIES' DIFFERENCES IN THE EFFECT OF SERUM GAMMA-GLOBULIN CONCENTRATION ON GAMMA-GLOBULIN CATABOLISM.
    SELL S
    J Exp Med; 1964 Nov; 120(5):967-86. PubMed ID: 14247732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of beryllium lymphocyte transformation tests in chronic beryllium disease.
    Williams WR; Williams WJ
    Int Arch Allergy Appl Immunol; 1982; 67(2):175-80. PubMed ID: 7056594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of the functional state of the lymphocytes in berylliosis studied by the blast transformation method].
    Shpakova AP; Ermakova NG
    Sov Med; 1979 Apr; (4):20-4. PubMed ID: 312533
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.
    Fontenot AP; Palmer BE; Sullivan AK; Joslin FG; Wilson CC; Maier LA; Newman LS; Kotzin BL
    J Clin Invest; 2005 Oct; 115(10):2886-93. PubMed ID: 16151531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
    Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG
    N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of chronic berylliosis].
    Schreiber J; Zissel G; Greinert U; Galle J; Schulz KH; Schlaak M; Müller-Quernheim J
    Pneumologie; 1999 Apr; 53(4):193-8. PubMed ID: 10409861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic kinetics, distribution and elimination of beryllium from the body].
    Zhuravlve VF; Bugryshev PF
    Gig Sanit; 1974 Oct; (10):74-7. PubMed ID: 4618827
    [No Abstract]   [Full Text] [Related]  

  • 15. Abolition of natural tolerance and the influence of the chemical allergen beryllium on autoimmune processes.
    Alekseeva OG; Vasil'eva EV; Orlova AA
    Bull World Health Organ; 1974; 51(1):51-8. PubMed ID: 4549042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a standardised method for determining beryllium in human urine at nanogram level.
    Devoy J; Melczer M; Antoine G; Remy A; Heilier JF
    Anal Bioanal Chem; 2013 Oct; 405(25):8327-36. PubMed ID: 23892880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease.
    Palmer BE; Mack DG; Martin AK; Maier LA; Fontenot AP
    J Allergy Clin Immunol; 2007 Jul; 120(1):184-91. PubMed ID: 17416406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A canine model of beryllium-induced granulomatous lung disease.
    Haley PJ; Finch GL; Mewhinney JA; Harmsen AG; Hahn FF; Hoover MD; Muggenburg BA; Bice DE
    Lab Invest; 1989 Aug; 61(2):219-27. PubMed ID: 2755079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behaviour of urinary beryllium in general population and in subjects with low-level occupational exposure.
    Apostoli P; Porru S; Alessio L
    Med Lav; 1989; 80(5):390-6. PubMed ID: 2695803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalized immune response reflects clinical severity of beryllium disease.
    Newman LS; Bobka C; Schumacher B; Daniloff E; Zhen B; Mroz MM; King TE
    Am J Respir Crit Care Med; 1994 Jul; 150(1):135-42. PubMed ID: 8025739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.